Cat.#: ACPP-1274
| Despition | Visfatin Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1207 | Dopamine Receptor D1 Blocking Peptide (AC1207) | 250 µg | inquiry |
| ACPP-1309 | CCR5 Blocking Peptide (AC1309) | 250 µg | inquiry |
| ACPP-1094 | Recombinant Human FGFR4 Protein (Functional) (AC1094) | 10 µg | inquiry |
| ACPP-1298 | Syndecan-1 Blocking Peptide (AC1298) | 250 µg | inquiry |
| ACPP-1381 | Human DTNBP1 Protein (AC1381) | 5 µg | inquiry |
| ACPP-1580 | Mouse LGALS9 Protein (AC1580) | 2 µg | inquiry |
| ACPP-1718 | Human ASRGL1 Protein (AC1718) | 2 µg | inquiry |
| ACPP-1139 | Recombinant Human Cadherin 10 Protein (6×His Tag) (AC1139) | 50 µg | inquiry |
| ACPP-1438 | Human NDRG2 Protein (AC1438) | 5 µg | inquiry |
| ACPP-1696 | Human GHRL Protein (AC1696) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.